Article Text

Download PDFPDF
Revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment
  1. Sylvia Broeders1,
  2. Sylvie Goletti2,
  3. Jean-Paul Tomasi2,
  4. Carolien Bonroy3,
  5. René-Louis Humbel4,
  6. Laurence Lutteri5,
  7. Sofie Schouwers6,
  8. Lieve Van Hoovels7,
  9. Martine Vercammen8,
  10. Xavier Bossuyt9
  1. 1 Quality of Laboratories, Sciensano, Brussels, Belgium
  2. 2 Cliniques Universitaires Saint-Luc, Brussels, Belgium
  3. 3 Laboratory Medicine, University Hospitals Gent, Ghent, Belgium
  4. 4 BioneXt Lab Leudelange, Grand Duchy of Luxembourg, Leudelange, Luxembourg
  5. 5 Department of Clinical Chemistry, University Hospital of Liège, Liège, Belgium
  6. 6 Laboratory Medicine, GasthuisZusters Antwerp, Antwerp, Belgium
  7. 7 Laboratory Medicine, OLVZ Aalst, Aalst, Belgium
  8. 8 Martine Vercammen, Laboratory Medicine, AZ Sint-Jan Brugge, Brugge, Belgium
  9. 9 Laboratory Medicine, University Hospitals Leuven and Department of Microbiology and Immunology, Leuven, Belgium
  1. Correspondence to Dr Xavier Bossuyt, Laboratory Medicine, University Hospitals Gasthuisberg, Herestraat 49, Leuven 3000, Belgium; xavier.bossuyt{at}

Statistics from

We read with great interest the multicentre study of Damoiseaux et al 1–3 on the detection of antineutrophil cytoplasmic antibodies (ANCA). ANCAs are important laboratory markers to support the diagnosis of ANCA-associated small vessel vasculitis (AAV), including granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). Traditionally, laboratories screen for ANCA by indirect immunofluorescence (IIF) and IIF positive samples are further evaluated for antibodies to proteinase 3 (PR3) or myeloperoxidase (MPO) by specific immunoassays. Such diagnostic algorithm is based on an international consensus statement on ANCA testing issued in 1999.4 Over the last two decades, the diagnostic performance of immunoassays has significantly improved. The recent multicentre study showed a …

View Full Text


  • Contributors SB organised the study, analysed the data and summarised the results. SG and JPT provide the patient sample. SB, SG, JPT, CB, RLH, LL, MV, SS, LVH and XB discussed the data and revised the manuscript. XB wrote the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests XB has been a consultant to Inova Diagnostics and to Thermo Fisher.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles